ES2182524T3 - Composiciones de hidroxiomeprazol y sus utilizaciones. - Google Patents

Composiciones de hidroxiomeprazol y sus utilizaciones.

Info

Publication number
ES2182524T3
ES2182524T3 ES99922802T ES99922802T ES2182524T3 ES 2182524 T3 ES2182524 T3 ES 2182524T3 ES 99922802 T ES99922802 T ES 99922802T ES 99922802 T ES99922802 T ES 99922802T ES 2182524 T3 ES2182524 T3 ES 2182524T3
Authority
ES
Spain
Prior art keywords
hydroxyomeprazol
compositions
pharmaceutically acceptable
hydroxyomeprazole
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99922802T
Other languages
English (en)
Spanish (es)
Inventor
William E Yelle
Dean A Handley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ES2182524T3 publication Critical patent/ES2182524T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES99922802T 1998-05-05 1999-05-05 Composiciones de hidroxiomeprazol y sus utilizaciones. Expired - Lifetime ES2182524T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8425898P 1998-05-05 1998-05-05

Publications (1)

Publication Number Publication Date
ES2182524T3 true ES2182524T3 (es) 2003-03-01

Family

ID=22183810

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99922802T Expired - Lifetime ES2182524T3 (es) 1998-05-05 1999-05-05 Composiciones de hidroxiomeprazol y sus utilizaciones.

Country Status (9)

Country Link
US (2) US6294586B1 (https=)
EP (1) EP1082114B1 (https=)
JP (1) JP2003517434A (https=)
AT (1) ATE222764T1 (https=)
AU (1) AU748872B2 (https=)
CA (1) CA2330049A1 (https=)
DE (1) DE69902657T2 (https=)
ES (1) ES2182524T3 (https=)
WO (1) WO1999056746A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420435B1 (en) * 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
WO2004064719A2 (en) * 2003-01-24 2004-08-05 State Of Israel, Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.

Also Published As

Publication number Publication date
WO1999056746A1 (en) 1999-11-11
EP1082114A1 (en) 2001-03-14
AU748872B2 (en) 2002-06-13
EP1082114B1 (en) 2002-08-28
US6294586B1 (en) 2001-09-25
CA2330049A1 (en) 1999-11-11
AU3971699A (en) 1999-11-23
ATE222764T1 (de) 2002-09-15
US6498171B2 (en) 2002-12-24
JP2003517434A (ja) 2003-05-27
DE69902657D1 (de) 2002-10-02
US20020010196A1 (en) 2002-01-24
DE69902657T2 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
IL141762A0 (en) New oral formulations
MX9706449A (es) Composicion farmaceutica para compuestos de piperidinalcanol.
CY1106072T1 (el) Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
AR064895A2 (es) Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina
ATE284695T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend 2-methyl-thienobenzodiazepin
FI963984L (fi) Uusi oraalinen farmaseuttinen annostelumuoto
ES2159591T3 (es) Composicion de liberacion controlada.
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
SE9700885D0 (sv) New pharmaceutical formulation
AR043071A1 (es) Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
CO4230093A1 (es) Derivados del indol y sus usos medicos
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
GB9907571D0 (en) Compounds
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ES2182524T3 (es) Composiciones de hidroxiomeprazol y sus utilizaciones.
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
CO5210869A1 (es) Una combinacion sinergetica: gabapentina y pregabalina
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
CO4930269A1 (es) Composiciones farmaceuticas